157 related articles for article (PubMed ID: 9857467)
1. [Inhibition of thrombocyte aggregation after heart valve replacement].
von Schacky C
Z Kardiol; 1998; 87 Suppl 4():46-55. PubMed ID: 9857467
[TBL] [Abstract][Full Text] [Related]
2. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
3. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
[TBL] [Abstract][Full Text] [Related]
4. Late incidence and determinants of stroke after aortic and mitral valve replacement.
Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
[TBL] [Abstract][Full Text] [Related]
5. [Optimum anticoagulation control after bileaflet mechanical valve replacement: a prospective multi-institutional study].
Kitamura M; Koyanagi H; Kawada S; Hosoda Y; Kurosawa H; Takeuchi Y; Kawase M; Wanibuchi Y
Kyobu Geka; 1999 Nov; 52(12):1001-4. PubMed ID: 10554485
[TBL] [Abstract][Full Text] [Related]
6. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement.
Koertke H; Minami K; Boethig D; Breymann T; Seifert D; Wagner O; Atmacha N; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
Circulation; 2003 Sep; 108 Suppl 1():II75-8. PubMed ID: 12970212
[TBL] [Abstract][Full Text] [Related]
7. [Intensity of oral anticoagulant therapy after heart valve replacement].
Stenzinger W
Z Kardiol; 1998; 87 Suppl 4():37-41. PubMed ID: 9857465
[TBL] [Abstract][Full Text] [Related]
8. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
[TBL] [Abstract][Full Text] [Related]
9. [The long term (15 years) evolution after valvular replacement with mechanical prosthesis or bioprosthesis between the age of 60 and 70 years].
Hanania G; Michel PL; Montély JM; Warembourg H; Nardi O; Leguerrier A; Agnino A; Despins P; Legault B; Petit H; Bouraindeloup M;
Arch Mal Coeur Vaiss; 2004 Jan; 97(1):7-14. PubMed ID: 15002704
[TBL] [Abstract][Full Text] [Related]
10. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
Aramendi JL; Agredo J; Llorente A; Larrarte C; Pijoan J
J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
[TBL] [Abstract][Full Text] [Related]
11. [Thromboembolic and bleeding complications in patients treated with oral anticoagulant therapy after mechanical heart valve prostheses implantation].
Kanaoka Y; Tanemoto K; Murakami T; Kuroki K
Kyobu Geka; 2000 Aug; 53(9):754-8. PubMed ID: 10935402
[TBL] [Abstract][Full Text] [Related]
12. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
Dale J; Nitter-Hauge S
Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
[No Abstract] [Full Text] [Related]
13. [Aortic valve replacement: technique and outcome with artificial heart valves and allografts].
Vogt PR; Turina MI
Ther Umsch; 1998 Dec; 55(12):737-45. PubMed ID: 10025187
[TBL] [Abstract][Full Text] [Related]
14. Lower-intensity anticoagulation for mechanical heart valves: a new concept with the ATS bileaflet aortic valve.
Van Nooten GJ; Van Belleghem Y; Caes F; François K; Van Overbeke H; Bové T; Taeymans Y
J Heart Valve Dis; 2003 Jul; 12(4):495-501; discussion 502. PubMed ID: 12918853
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
Stein PD; Alpert JS; Dalen JE; Horstkotte D; Turpie AG
Chest; 1998 Nov; 114(5 Suppl):602S-610S. PubMed ID: 9822066
[TBL] [Abstract][Full Text] [Related]
16. [Anticoagulation therapy in cardiac patients with mechanical valve prostheses].
Milosević U; Anojcić S
Srp Arh Celok Lek; 1990; 118(11-12):481-9. PubMed ID: 2133607
[TBL] [Abstract][Full Text] [Related]
17. Reduction of mechanical heart valve thrombosis through a clinical audit.
Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
Duveau D
Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
[No Abstract] [Full Text] [Related]
19. Antithrombotic therapy in native heart valve disease.
Völler H
J Heart Valve Dis; 2004 May; 13(3):325-8. PubMed ID: 15222275
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
Stein PD; Alpert JS; Bussey HI; Dalen JE; Turpie AG
Chest; 2001 Jan; 119(1 Suppl):220S-227S. PubMed ID: 11157651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
